18:44
2026-08-19
247wallst.com
artificial-intelligence
Moderna’s Cancer Breakthrough Just Made Tempus AI’s $1.5 Billion Bet Look Brilliant
Tempus AI's $1.5 billion acquisition of Personalis, announced July 20, 2026, looks prescient after Moderna and Merck reported positive Phase 3 results for mRNA-4157, a personalized cancer vaccine that…